NCT05009186

Brief Summary

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a worldwide pandemic in over 100 years. The disease caused by this newly discovered virus was called Covid-19. In this study, we aimed to evaluate changing of PSA value in patients with Covid-19.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable covid19

Timeline
Completed

Started Apr 2020

Typical duration for not_applicable covid19

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2020

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

August 15, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 17, 2021

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2021

Completed
Last Updated

August 17, 2021

Status Verified

August 1, 2021

Enrollment Period

1.5 years

First QC Date

August 15, 2021

Last Update Submit

August 15, 2021

Conditions

Covid19Prostate Specific Antigen

Keywords

Covid-19Prostate cancerProstate Specific Antigen

Outcome Measures

Primary Outcomes (1)

  • PSA value

    prostate specific antigen

    2 months

Secondary Outcomes (1)

  • Ferritin, CRP

    2 months

Study Arms (1)

Covid-19 group

OTHER

We will measure the PSA value during and after Covid-19 infection in the same group via paired simple t test

Other: PSA value

Interventions

PSA valueOTHER

We measure PSA value during and after covid-19 infection

Covid-19 group

Eligibility Criteria

Age45 Years - 70 Years
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsThe male patients \>45 and \<70 years of age included to the study
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male patients (\>45 and \<70 years of age) positive PCR test results were included in the study

You may not qualify if:

  • The patients \<45 and \>70 years of age who described lower urinary tract symptoms who had urinary tract infection who a history of prostate biopsy and previous high level of PSA who history of prostatitis were excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Omer Gokhan Doluoglu

Ankara, Altindag, 06100, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

COVID-19Prostatic Neoplasms

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesGenital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital Diseases

Study Officials

  • Omer G Doluoglu, Associate Professor

    Ankara Training and Research Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Omer G Doluoglu, Associate Professor

CONTACT

+905332157809drdoluoglu@yahoo.com.tr

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: We measured PSA value during and after Covid-19 infection
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ankara Training and Research Hospital

Study Record Dates

First Submitted

August 15, 2021

First Posted

August 17, 2021

Study Start

April 1, 2020

Primary Completion

October 1, 2021

Study Completion

October 1, 2021

Last Updated

August 17, 2021

Record last verified: 2021-08

Locations

TU(1)